PMCB

PharmaCyte Biotech Inc

PMCB.US pharmacyte.com + Research + Basket
CIK 0001157075
Employees 2
Phone 917 595 2850
Fiscal year end April
IPO Sep 17, 2010
Address 3960 Howard Hughes Parkway, Las Vegas, NV, United States, 89169
0.36
+0.02 (+5.45%)
USD · NASDAQ
52-week range
0.33
1.51
Trading at 2% of the 52-week range
Market Cap
3.68M
P/E Ratio
0.00
Forward P/E
7.02
Book Value
2.60
Div. Yield
N/A
% Institutions
7.11%
% Insiders
5.74%

1 Year

-65.2%

3 Year

-83.6%

10 Year

-99.4%
Description

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.

Actions

Add an action for PMCB.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Joshua N. Silverman CEO. President & Executive Chairman 1970
Mr. Carlos A. Trujillo CPA Chief Financial Officer 1958
Dr. Jose L. Iglesias M.D. Consulting Chief Medical Officer 1957
Dr. Hans-Peter Hammes M.D. Member of Medical & Scientific Advisory Board and Consultant NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Jan 07, 2026 Jonathan Schechter N/A Purchase 20.00K $0.84 $16.80K SEC
Jan 07, 2026 Joshua Silverman N/A Purchase 40.00K $0.83 $33.20K SEC
Jan 05, 2026 Jonathan Schechter N/A Purchase 20.00K $0.78 $15.60K SEC
Jan 05, 2026 Joshua Silverman N/A Purchase 30.00K $0.78 $23.40K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Citadel Advisors Llc 283.38K Jun 30, 2026 2.64% $0.00 -21.18%
Geode Capital Management, LLC 124.25K Jun 30, 2026 1.16% $0.00 -36.50%
Vanguard Capital Management, LLC 56.78K Jun 30, 2026 0.53% $0.00 10.32%
Susquehanna International Group, LLP 44.85K Jun 30, 2026 0.42% $0.00 0.00%
Renaissance Technologies Corp 37.99K Jun 30, 2026 0.35% $0.00 -32.77%
XTX Topco Ltd 34.18K Jun 30, 2026 0.32% $0.00 -34.72%
Northern Trust Corp 32.62K Jun 30, 2026 0.30% $0.00 -8.36%
Jane Street Group LLC 30.06K Jun 30, 2026 0.28% $0.00 160.75%
Schonfeld Strategic Advisors LLC 26.93K Jun 30, 2026 0.25% $0.00 -0.31%
Vanguard Fiduciary Trust Co 23.45K Jun 30, 2026 0.22% $0.00 0.00%
EQUITEC PROPRIETARY MARKETS, LLC 22.23K Jun 30, 2026 0.21% $0.00 0.00%
Commonwealth Equity Services, LLC 20.26K Jun 30, 2026 0.19% $0.00 96.40%
HRT FINANCIAL LLC 15.45K Jun 30, 2026 0.14% $0.00 -37.55%
Tower Research Capital LLC 4.89K Jun 30, 2026 0.05% $0.00 -0.02%
UBS Group AG 4.14K Jun 30, 2026 0.04% $0.00 -8.34%
Group One Trading, LLC 500.00 Jun 30, 2026 0.00% $0.00 -71.99%
Advisor Group Holdings, Inc. 303.00 Jun 30, 2026 0.00% $0.00 0.33%
Covestor Ltd 275.00 Jun 30, 2026 0.00% $0.00 0.00%
Barclays PLC 192.00 Jun 30, 2026 0.00% $0.00 0.00%
Sachetta LLC 14.00 Jun 30, 2026 0.00% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Extended Market Index 58.24K 0.54% ▼ 0.53% Aug 31, 2026
2 Fidelity Nasdaq Composite Index 17.45K 0.16% ▲ 0.00% Aug 31, 2026
3 Fidelity Total Market Index 15.26K 0.14% ▲ 0.00% Aug 31, 2026
4 Fidelity Series Total Market Index 12.90K 0.12% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $3.68M
PEG Ratio: $0.00
Book Value: $2.60
Earnings/Share: $-2.31
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -8.35%
ROE (TTM): -43.99%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $-24.94M
Trailing P/E: 0.00
Forward P/E: 7.02

Shares Statistics

Shares Outstanding: 10.74M
Shares Float: 10.07M
% Insiders: 5.74%
% Institutions: 7.11%
Short % Float: 0.69%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Gross Profit
subtotal
$0.00
SG&A
adjust
$-4.91M
R&D
adjust
$-391.30K
Other Operating Expense
adjust
$-1.55M
Operating Income
subtotal
$-6.85M
Other / Non-Operating Items
adjust
$-12.57M
Net Income
subtotal
$-19.42M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PMCB.US!